Biorestorative TherapiesBRTX
13F holders, Q4 2024 (December 31)15holders
1new positions
2sold out
1famous investor
$1.43avg. 13F price*
At the end of Q4 2024, 15 institutions reported holding Biorestorative Therapies Inc. (BRTX) in their 13F filings, unchanged from Q3 2024. 1 opened new positions and 2 sold out. The largest holders were Geode Capital Management, LLC ($78K), StoneX Group Inc. ($72K) and Wealth Alliance, LLC ($57K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Biorestorative Therapies Inc.
- CUSIP
- 090655606
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $31K |
| Exits | 2 | $57K |
All 13F filers, Q3 2024 → Q4 2024: 48,085 shares bought and 36,718 shares sold, net +11,367 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 15 holders
| Geode Capital Management, LLC | 0.00% | Reduce -1.8% | 54,722 | $78K |
| StoneX Group Inc. | 0.00% | Reduce -4.5% | 50,143 | $72K |
| Wealth Alliance, LLC | 0.01% | No change | 40,000 | $57K |
| Morgan Stanley | 0.00% | Add +57.1% | 27,500 | $39K |
| Citadel Advisors | 0.00% | New | 21,481 | $31K |
| Vanguard Group Inc. | 0.00% | No change | 20,472 | $29K |
| State Street Corp. | 0.00% | No change | 20,459 | $29K |
| US Financial Advisors, LLC | 0.01% | No change | 17,142 | $25K |
| UBS Group AG | 0.00% | Add +2251.7% | 16,297 | $23K |
| Newman Dignan & Sheerar, Inc. | 0.00% | Add +9.5% | 11,522 | $16K |
| Osaic Holdings, Inc. | 0.00% | No change | 2,193 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -26.7% | 1,577 | $2K |
| SBI Securities Co., Ltd. | 0.00% | — | 60 | $86 |
| Bank of America Corp. | 0.00% | No change | 42 | $60 |
| TD Waterhouse Canada Inc. | 0.00% | No change | 2 | $3 |
"% of holder's portfolio" is BRTX's weight in each manager's 13F, not the share of Biorestorative Therapies Inc. the manager owns.